Wikidata

(Q63835866)

English

BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
EXPLORE (English)
0 references
title
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA) (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
start time
June 2010
0 references
end time
March 2012
0 references
number of participants
108
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63835866&oldid=2234586040"